Diversify Advisory Services’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Diversify Advisory Services's IBRX Position: Q2 2026 in Review
Diversify Advisory Services opened a new position in ImmunityBio (IBRX) in Q2 2026: 14,896 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #1222 among its holdings. This is a return to the name: Diversify Advisory Services previously reported a position in IBRX as recently as Q4 2025.
Diversify Advisory Services first reported a position in IBRX in Q2 2025 and has held it in 4 quarters since. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.
- Diversify Advisory Services held 14,896 shares of ImmunityBio worth $104K as of Q2 2026.
- ImmunityBio was a new Diversify Advisory Services position in Q2 2026.
- ImmunityBio made up ﹤0.01% of Diversify Advisory Services's portfolio in Q2 2026, its #1222 holding.
- Diversify Advisory Services first reported a position in ImmunityBio in Q2 2025 and has held it in 4 quarters since.
- 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.
Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.